5-HT1A receptor agonist
This page covers all 5-HT1A receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-HT1A receptor.
Targets
Marketed (2)
- Usual dose treatment of Tandospirone · Sumitomo Pharma (Suzhou) Co., Ltd. · Psychiatry/Neurology
Tandospirone is a serotonin 1A (5-HT1A) receptor agonist that enhances serotonergic neurotransmission in the central nervous system. - Buspirone HCl · Par Pharmaceutical, Inc. · Psychiatry/Neurology
Buspirone acts as a serotonin 5-HT1A receptor agonist to reduce anxiety without the sedation or dependence associated with benzodiazepines.
Phase 3 pipeline (1)
- SPN-810 (18 mg) · Supernus Pharmaceuticals, Inc. · Psychiatry/Neurology
SPN-810 is a selective serotonin 5-HT1A receptor agonist that modulates serotonergic neurotransmission to reduce impulsivity and improve behavioral control.
Patent intelligence
- 5 ht1a receptor agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates